US Patent 6878721 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Novartis Pharmaceuticals Corporation

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

dksh-m-2025-05-26

Contact Supplier

dmfs-not-supported-m-2025-05-19

TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Contact Supplier

LEBSA- Your strategic API source for niche molecules.

Contact Supplier

jdmfs-not-supported-m-2025-04-28

Novartis Pharmaceuticals Corporation

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Corporate Presentation

Corporate Presentation

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 4950 News #PharmaBuzz

Interview #SpeakPharma
Vlog #PharmaReel
Data Compilation #PharmaFlow
4950 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

86 All APIs, 42 USDMF, 4 CEP/COS, 5 JDMF, 28 KDMF, 15 NDC API, 1 VMF, 1 Listed APIs

86 All APIs
42 USDMF
4 CEP/COS
5 JDMF
28 KDMF
15 NDC API
1 VMF
1 Listed APIs

DEVELOPMENTS

325 Drugs in Development

325 Drugs in Development

FINISHED DOSAGE FORMULATIONS

1459 FDF Dossiers, 374 FDA Orange Book, 349 Europe, 169 Canada, 564 Australia, 3 Listed Dossiers

1459 FDF Dossiers
374 FDA Orange Book
349 Europe
169 Canada
564 Australia
3 Listed Dossiers

EXCIPIENTS

3 All Excipients, 3 USDMF

3 All Excipients
3 USDMF

INSPECTIONS & REGISTRATIONS

33 FDA, 1 EDQM, 2 GDUFA

33 FDA
1 EDQM
2 GDUFA

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2NOVARTIS

filter Patent Number Reset all filters

2 All

01 26878721

filter API Patent Reset all filters

2 All

01 2Y

filter FDF Patent Reset all filters

2 All

01 2Y

filter Expiration Date Reset all filters

2 All

01 22025-02-25

01

NOVARTIS

INDACATEROL MALEATE

GRx+Biosims

Not Confirmed

NOVARTIS

GRx+Biosims

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-02-25

INDACATEROL MALEATE

US Patent Number : 6878721

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 22383

Patent Use Code : U-1168

Delist Requested :

Patent Use Description : THE LONG TERM, ONCE-DA...

Patent Expiration Date : 2025-02-25

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

NOVARTIS

GLYCOPYRROLATE; INDACATEROL MALEATE

GRx+Biosims

Not Confirmed

NOVARTIS

GRx+Biosims

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-02-25

GLYCOPYRROLATE; INDACATEROL MALEATE

US Patent Number : 6878721

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 207930

Patent Use Code : U-1773

Delist Requested :

Patent Use Description : LONG - TERM MAINTENANC...

Patent Expiration Date : 2025-02-25

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!